Reckitt Benckiser Gives Consumer Health Portfolio Its Own Home – What's Next?
Executive Summary
UK manufacturer in January begins operating with a separate health care division, representing 60% of sales with products including Mucinex and Mead Johnson infant and adult formulas, and a home care/hygiene division led by Lysol disinfectants. The plan piques analysts' expectations that operating the divisions separately will lead to divesting one.
You may also be interested in...
Merck, Pfizer Decorate Consumer Health 'For Sale' Signs With Strong Results
Merck KGAA reports 11% growth in sales of its OTC lines over a year ago, but, like Pfizer, looks to sharpen its long-term focus on the Rx business.
Merck, Pfizer Decorate Consumer Health 'For Sale' Signs With Strong Results
Merck KGAA reports 11% growth in sales of its OTC lines over a year ago, but, like Pfizer, looks to sharpen its long-term focus on the Rx business.
'For Sale' Signs In Consumer Health Sector As Firms Sharpen Pharma Focus
Freeing up spending for their Rx businesses prompt Merck KGAA to look at selling its division marketing Nasivin OTC nasal sprays, Omnibionta probiotic vitamins and other brands, and Pfizer to shop its consumer business with Advil analgesics, Centrum multivitamins and other OTC and dietary supplement brands.